Drug

Dronabinol

Established medicine

ClassCannabinoid CB1 receptor agonistResearchOngoing clinical research

Also known as (-)-delta9-trans-Tetrahydrocannabinol, .DELTA.1-THC, 1-trans-delta-9-Tetrahydrocannabinol, Delta-9-tetrahydrocannabinol+13 more

(-)-delta9-trans-Tetrahydrocannabinol, .DELTA.1-THC, 1-trans-delta-9-Tetrahydrocannabinol, Delta-9-tetrahydrocannabinol, Marinol, Syndros, THC, Tetrahydrocannabinol, delta 9-tetrahydrocannabinol, delta(1)-tetrahydrocannabinol, delta(9)-THC, delta-9-THC, delta9-tetrahydrocannabinol, tetrahydrocannabinol (THC), 3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol, Dronabinolum, Synthetic delta-9-Tetrahydrocannabinol.

RxNorm10402 ChEMBLCHEMBL465 ATCA04AD10UNII7J8897W37S

Research papers

Active clinical trials

Cannabinoid receptor 1

Primary target

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee

Clinical trial2026-09-04Results expected Q1 2027 · ClinicalTrials.gov

Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans

Clinical trial2026-09-02Results expected Q4 2028 · ClinicalTrials.gov

BONG: Reducing Severe Breathlessness With Dronabinol in the Severe and Very Severe Chronic Obstructive Pulmonary Disease Patient Group - A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Clinical trial2026-09-01Primary completion · ClinicalTrials.gov

The Differential Effects of THC vs. CBD on Cognition in Persons With MS

Clinical trial2026-09-01Primary completion · ClinicalTrials.gov

The Pharmacokinetics of a Hemp-Based Topical Cannabinoid Product in a Sanitized and Controlled Environment

Clinical trial2026-08-01Primary completion · ClinicalTrials.gov

Effects of Drugs on Stress Memories

Clinical trial2026-07-09Results posted · ClinicalTrials.gov

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

Presynaptic nanoscale components of retrograde synaptic signaling.

Research2024-05-29Science advances

Cannabis effects on driving skills.

Research2012-12-07Clinical chemistry

Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Research2012-01-30Neurogastroenterology and motility

Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome.

Research2011-07-29Gastroenterology

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name

Dronabinol

Aliases & brands

(-)-delta9-trans-Tetrahydrocannabinol.DELTA.1-THC1-trans-delta-9-TetrahydrocannabinolDelta-9-tetrahydrocannabinolMarinolSyndrosTHCTetrahydrocannabinoldelta 9-tetrahydrocannabinoldelta(1)-tetrahydrocannabinoldelta(9)-THCdelta-9-THCdelta9-tetrahydrocannabinoltetrahydrocannabinol (THC)3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-olDronabinolumSynthetic delta-9-Tetrahydrocannabinol

RxNorm CUI

10402

ChEMBL ID

CHEMBL465

ATC codes

A04AD10

UNII

7J8897W37S

Primary mechanism

Cannabinoid CB1 receptor agonist